首页|期刊导航|中华医学杂志（英文版）|Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia

Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia

Danni Xie Bing Wang Xue Bai Xin Jin Wenyi Lu Meng Zhang Yi Zhang Xinping Cao Mingfeng Zhao

中华医学杂志（英文版）2025，Vol.138Issue(1)：114-116,3.

中华医学杂志（英文版）2025，Vol.138Issue(1)：114-116,3.DOI:10.1097/CM9.0000000000003362

Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia

Danni Xie ¹Bing Wang ²Xue Bai ²Xin Jin ³Wenyi Lu ²Meng Zhang ¹Yi Zhang ¹Xinping Cao ¹Mingfeng Zhao²

作者信息

1. First Central Clinical College,Tianjin Medical University,Tianjin 300110,China
2. Department of Hematology,Tianjin First Central Hospital,Tianjin 300192,China
3. Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou,Zhejiang 310011,China
折叠

摘要

引用本文复制引用

Danni Xie,Bing Wang,Xue Bai,Xin Jin,Wenyi Lu,Meng Zhang,Yi Zhang,Xinping Cao,Mingfeng Zhao..Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia[J].中华医学杂志（英文版）,2025,138(1):114-116,3.

基金项目

This work was supported by grants from the General Project of the National Natural Science Foundation of China(No.81970180),the Science and Technology Project of Tianjin Municipal Health Committee(No.TJWJ2022QN030),the Key Projects of Tianjin Applied Basic Research and Multi-Investment Fund(No.21JCZDJC01240),the Science and Technology Project of Tianjin Municipal Health Committee(No.TJWJ2022XK018),the Tianjin Key Medical Discipline(Specialty)Construction Project(No.TJYXZDXK-056B),the Tianjin Municipal Natural Science Foundation(No.22JCQNJC00820),the Tianjin Health Research Project(No.TJWJ2023QN027),the Tianjin Health Bureau Project(No.ZC20074),and the Tianjin Key Medical Discipline(Specialty)Construction Project(No.TJWJ2023XK010). （No.81970180）

中华医学杂志（英文版）

ISSN：0366-6999

访问量0

下载量0

段落导航